A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus.
暂无分享,去创建一个
R C Elston | T Nagatsu | R. Elston | J. Gelernter | K. Kim | G. Anderson | J. Cubells | H. Ichinose | R. Malison | C. Zabetian | S. Buxbaum | T. Nagatsu | S G Buxbaum | G M Anderson | J Gelernter | K S Kim | C P Zabetian | H Ichinose | C H Kim | R T Malison | J F Cubells | C. Kim | Robert C. Elston | Toshiharu Nagatsu | Sarah G. Buxbaum | Joel Gelernter | Cyrus P. Zabetian | George M. Anderson | Hiroshi Ichinose | Kwang-Soo Kim | Chun-Hyung Kim
[1] R. Glass,et al. Plasma dopamine-beta-hydroxylase in depressed patients. , 1982, Biological psychiatry.
[2] Walter L. Smith. Probability and Statistics , 1959, Nature.
[3] G. Sedvall,et al. Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals--a genetic study. , 1986, Journal of psychiatric research.
[4] D. Cox,et al. An Analysis of Transformations , 1964 .
[5] T Nagatsu,et al. Human dopamine beta-hydroxylase gene: two mRNA types having different 3'-terminal regions are produced through alternative polyadenylation. , 1989, Nucleic acids research.
[6] Kazuto Kobayashi,et al. Dopamine β-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation , 1998, Human Genetics.
[7] N. Risch. Searching for genetic determinants in the new millennium , 2000, Nature.
[8] J. Mallet,et al. The primary structure of human dopamine‐beta‐hydroxylase: insights into the relationship between the soluble and the membrane‐bound forms of the enzyme. , 1987, The EMBO journal.
[9] R. Elston,et al. Segregation and linkage analyses of dopamine-beta-hydroxylase activity. , 1979, Human heredity.
[10] J. Phillips,et al. Linkage analysis of the human dopamine beta-hydroxylase gene. , 1991, Genomics.
[11] K. Kidd,et al. Population genetics of a functional variant of the dopamine beta-hydroxylase gene (DBH). , 1997, American journal of medical genetics.
[12] K. Kidd,et al. Sequence tagged site (STS) TaqI RFLP at dopamine beta-hydroxylase (DBH). , 1991, Nucleic acids research.
[13] R. Weinshilboum,et al. Serum dopamine-beta-hydroxylase activity: sibling-sibling correlation. , 1973, Science.
[14] K. Druschky,et al. Differentiation of Parkinson’s disease and multiple system atrophy in early disease stages by means of I-123-MIBG–SPECT , 2000, Journal of the Neurological Sciences.
[15] J. Gelernter,et al. Functional variants at CYP2A6: new genotyping methods, population genetics, and relevance to studies of tobacco dependence. , 2000, American journal of medical genetics.
[16] R. Weinshilboum,et al. Human serum dopamine beta-hydroxylase: correlation of enzymatic activity with immunoreactive protein in genetically defined samples. , 1976, American journal of human genetics.
[17] R. Mathew,et al. Depression, antidepressants, and plasma DBH , 1981, Psychiatry Research.
[18] J. Mallet,et al. Localization of the human dopamine beta hydroxylase (DBH) gene to chromosome 9q34. , 1988, Cytogenetics and cell genetics.
[19] R. Teradaira,et al. SERUM DOPAMINE‐β‐HYDROXYLASE IN SCHIZOPHRENIC PATIENTS , 1978 .
[20] M. Goldstein,et al. SERUM DOPAMINE-β-HYDROXYLASE ACTIVITY IN PATIENTS WITH HUNTINGTON'S CHOREA AND PARKINSON'S DISEASE , 1972 .
[21] R. Weinshilboum,et al. Serum Dopamine-β-Hydroxylase Activity: Sibling-Sibling Correlation , 1973, Science.
[22] N. Winer,et al. Effect of cold pressor stimulation on plasma norepinephrine, dopamine-beta-hydroxylase, and renin activity. , 1977, Life sciences.
[23] B. Müller-Oerlinghausen,et al. Longitudinal assessment of MAO-, COMT-, and DBH- activity in patients with bipolar depression. , 1982, International pharmacopsychiatry.
[24] K. Wakabayashi,et al. Neuropathology of autonomic nervous system in Parkinson's disease. , 1997, European neurology.
[25] R Imaizumi,et al. Distribution of dopamine-beta-hydroxylase in subcellular fractions of adrenal medulla. , 1967, Life sciences.
[26] T. Joh,et al. Neuron-specific expression of the human dopamine beta-hydroxylase gene requires both the cAMP-response element and a silencer region. , 1993, The Journal of biological chemistry.
[27] J. Phillips,et al. Linkage analysis of the human dopamine β-hydroxylase gene , 1991 .
[28] L. Wetterberg,et al. Genetic control of plasma dopamine- β -hydroxylase , 1973 .
[29] R. Weinshilboum,et al. Inheritance of very low serum dopamine-beta-hydroxylase activity. , 1975, American journal of human genetics.
[30] D. O'Connor,et al. Immunocytochemical localization of dopamine-β-hydroxylase in neurons of the human brain stem , 1987, Neuroscience.
[31] C. Ramchand,et al. Possible control of dopamine β-hydroxylase via a codominant mechanism associated with the polymorphic (GT)n repeat at its gene locus in healthy individuals , 1996, Human Genetics.
[32] N. Shen,et al. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis , 1999, Nature Genetics.
[33] R. Weinshilboum. Serum dopamine beta-hydroxylase. , 1978, Pharmacological reviews.
[34] E. Mercer,et al. Cell-specific expression from the human dopamine beta-hydroxylase promoter in transgenic mice is controlled via a combination of positive and negative regulatory elements , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[35] S. Daniel,et al. Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson's disease – a retrospective comparison , 1995, Acta neurologica Scandinavica.
[36] O. H. Viveros,et al. Release of catecholamines and dopamine-β-oxidase from the adrenal medulla , 1968 .
[37] H. Meltzer,et al. Serum dopamine-beta-hydroxylase activity in schizophrenia. , 1980, Biological psychiatry.
[38] R. Elston,et al. Segregation and Linkage Analyses of Dopamine-β-Hydroxylase Activity , 1979 .
[39] J. Guilland,et al. Plasma norepinephrine, epinephrine, and dopamine beta-hydroxylase activity during exercise in man. , 1985, Medicine and science in sports and exercise.
[40] T. Sellers,et al. Stepwise oligogenic segregation and linkage analysis illustrated with dopamine-beta-hydroxylase activity. , 1990, American journal of medical genetics.
[41] D. Murphy,et al. Segregation and linkage studies of plasma dopamine-beta-hydroxylase (DBH), erythrocyte catechol-O-methyltransferase (COMT), and platelet monoamine oxidase (MAO): possible linkage between the ABO locus and a gene controlling DBH activity. , 1982, American journal of human genetics.
[42] J. Brunet,et al. Noradrenergic-Specific Transcription of the Dopamine β-Hydroxylase Gene Requires Synergy of MultipleCis-Acting Elements Including at Least Two Phox2a-Binding Sites , 1998, The Journal of Neuroscience.
[43] R. Weinshilboum,et al. Reduced plasma dopamine-beta-hydroxylase activity in familial dysautonomia. , 1971, The New England journal of medicine.
[44] R. Weinshilboum,et al. Serum Dopamine‐Beta‐Hydroxylase Activity , 1971, Circulation research.
[45] Z. Rihmer,et al. Reduced serum dopamine-beta-hydroxylase activity in paranoid schizophrenics. , 1983, Pharmacopsychiatria.
[46] M. Goldstein,et al. Serum dopamine-beta-hydroxylase activity in patients with Huntington's chorea and Parkinson's disease. , 1972, Lancet.
[47] R. Elston,et al. Linkage of a gene regulating dopamine-beta-hydroxylase activity and the ABO blood group locus. , 1988, American journal of human genetics.
[48] J. Turkka,et al. Serum noradrenaline response to standing up in patients with Parkinson's disease. , 1986, European neurology.
[49] T. Kondo,et al. Dopamine beta-hydroxylase activity in cerebrospinal fluid of Parkinsonian patients , 1982 .
[50] L. Price,et al. A haplotype at the DBH locus, associated with low plasma dopamine β-hydroxylase activity, also associates with cocaine-induced paranoia , 2000, Molecular Psychiatry.